Poster Presentation to Spotlight Ongoing Phase 1 Clinical Trial of EVOLVE104Oral and Poster Presentations to Highlight Preclinical Data ...
In a study published in Proceedings of the National Academy of Sciences, University of Alabama at Birmingham Department of Dermatology professors Chander Raman, Ph.D., and Mohammad Athar, Ph.D., and ...
According to an international multicenter study, CD2-negative mast cells are associated with significantly reduced overall survival in patients with SM. Patients with CD2-negative mast cells have ...
Figure 2: Bar graph showing the relative proportions (percentage of total recombinant CD2 produced which folds as an intertwined dimer) of dimer for wild type and mutant forms of CD2. Attempts to ...
Investigational microbiota-based live therapeutic RBX2660 was found to be safe and effective at reducing Clostridioides difficile (C difficile) recurrence, said Paul Feuerstadt, MD, assistant clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results